The NIH has launched a new campaign to educate the public on the link between high blood pressure and cognitive decline.
Higher baseline levels of N-terminal fragment of tau in the blood of healthy subjects was associated with an increased risk of developing cognitive deficits and Alzheimer's disease later in life.
Secondary infections and novel inflammatory events, even ones that occur external to the brain, amplify the brain's immune response and detrimentally impact cognition in mouse models of Alzheimer's disease.
A new paper explores different findings about the development of Alzheimer's and considers how personalized treatments may help combat this complex disease.
Researchers have developed a new machine learning algorithm that can make accurate predictions about cognitive decline leading to Alzheimer's. The algorithm, researchers say, may help doctors stream people onto a preventative path and offer treatment sooner.
Researchers report boosting levels of osteocalcin in the blood may help reverse age related memory loss in mice.
A new study reports high doses of resveratrol taken long term in people with mild to moderate Alzheimer's disease appears to impact a biomarker that usually declines as the disease progresses.